2016—2021年我国部分省级血液中心全血制备成分血供应能力分析  

Analysis on the blood components supply capacity of some provincial blood centers from 2016 to 2021

作　　者：张宁[1] 林永桔[2] 杨艺 卢长春[4] 马海莉[5] 关晓梅[6] 李小春[7] 李建民[8] 罗孟卓 顾晓东[10] 骆展鹏[11] 刘艳霞 李莹[13] 居兵[14] 曹晓莉[15] 白林 樊荣 栾芬[18] 孟跟东 王林[20] 邱艳[21] Zhang Ning;Lin Yongju;Yang Yi;Lu Changchun;Ma Haili;Guan Xiaomei;Li Xiaochun;Li Jianmin;Luo Mengzhuo;Gu Xiaodong;Luo Zhanpeng;Liu Yanxia;Li Ying;Ju Bing;Cao Xiaoli;Bai Lin;Fan Rong;Luan Fen;Meng Gendong;Wang Lin;Qiu Yan(Department of Blood Supply,Beijing Red Cross Blood Center,Beijing 100088,China)

机构地区：[1]北京市红十字血液中心供血科,100088 [2]广州血液中心业务管理部 [3]内蒙古自治区血液中心成分科 [4]黑龙江省血液中心业务科 [5]云南昆明血液中心行政办 [6]甘肃省红十字血液中心成分制备科 [7]成都市血液中心血液制备科 [8]河北省血液中心成分科 [9]长沙血液中心血液供应科 [10]乌鲁木齐市血液中心成分制备科 [11]重庆市血液中心血液制备科 [12]河南省红十字血液中心成分科 [13]江西省血液中心业务科 [14]山东省血液中心业务科 [15]陕西省血液中心业务科 [16]太原市血液中心办公室 [17]宁夏回族自治区血液中心供血服务科 [18]江苏省血液中心成分制备科 [19]辽宁省血液中心成分科 [20]海南省血液中心业务科 [21]北京市红十字血液中心办公室,100088

出　　处：《北京医学》2023年第6期538-543,共6页Beijing Medical Journal

摘　　要：目的探讨2016—2021年我国部分省级血液中心全血制备成分血供应能力及趋势。方法选取2016—2021年中国内地采供血机构执业比对平台的20家血液中心相关数据,分析全血制备成分血供应能力。结果2016—2021年全血年供应量呈现下降趋势,其中2021年较2016年降低62.87%,年平均供应量下降10.49%。2016—2021年,20家血液中心红细胞成分血供应量环比年增长率分别为8.46%、5.00%、9.01%、-6.72%和-1.31%,红细胞成分血供应率均>99.90%;千人口红细胞成分血供应量中位数分别为11.41 U、11.82 U、12.26 U、12.92 U、11.05 U和11.64 U;千人口血浆成分血供应量中位数分别为10.72 U、12.03 U、12.38 U,12.43 U,12.07 U和11.40 U。2019—2021年,20家血液中心红细胞成分血调剂量和血浆成分血调剂量均呈上升趋势。2016—2021年,浓缩血小板供应量环比年增长率分别为61.55%、126.34%、-69.49%、35.91%和-28.62%,冷沉淀凝血因子供应量环比年增长率分别为5.30%、-7.76%、5.46%、2.65%和-3.66%。结论我国部分省级血液中心红细胞成分血、血浆成分血、浓缩血小板、冷沉淀凝血因子供应能力不断提升,省级血液中心应结合自身条件不断优化,提高采供血服务能力。Objective To explore the blood supply of whole blood preparation components and their yearly changes in some provincial blood centers in China from 2016 to 2021.Methods The relevant data of 20 blood centers in the practice comparison platform of blood collection and supply institutions in China's Mainland from 2016 to 2021 were selected and the blood supply capacity and current situation of whole blood preparation components were analyzed.Results The annual supply of whole blood showed a decreasing trend from 2016 to 2021,with a decrease of 62.87 % in 2021 compared with 2016,and a decrease of 10.49 % in the average annual supply.The annual growth rates of red cell component blood supply in 20 blood centers were 8.46%,5.00%,9.01%,-6.72% and-1.31% from 2016 to 2021,respectively,and the blood supply rates of red cell component were all over 99.90%.The median blood supply of erythrocyte components of 1 000 population were 11.41 U,11.82 U,12.26 U,12.92 U,11.05 U and 11.64 U from 2016 to 2021,respectively.The median plasma component blood supply of 1 000 population was 10.72 U,12.03 U,12.38 U,12.43 U,12.07 U and 11.40 U from 2016 to 2021,respectively.The amount of red cell component and plasma component blood regulation in 20 blood centers showed an increasing trend from 2019 to 2021.The annual growth rates of concentrated platelet supply were 61.55%,126.34%,-69.49%,35.91% and-28.62% from 2016 to 2021,respectively.The annual growth rates of cryoprecipitated coagulation factor supply were 5.30%,-7.76%,5.46%,2.65% and-3.66% from 2016 to 2021,respectively.Conclusions The supply capacity of erythrocyte component blood,plasma component blood,concentrated platelets and cryoprecipitated coagulation factors in some provincial blood centers in China has been continuously improved.Provincial blood centers should continuously optimize their own conditions to improve blood collection and supply service capacity.

关 键 词：红细胞成分血 血浆成分血 血液供应 血液调剂 

分 类 号：R197.6[医药卫生—卫生事业管理]